CIK 0002123613 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-01 | 4 | 4 | 2026-09-29 |
| 2026-10-01 | 3 | 3 | 2026-09-29 |
| 2026-10-01 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-30 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-09-29 |
| 2026-08-13 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-13 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-11 | 8-K | 8-K items 2.02,9.01 | 2026-08-11 |
| 2026-08-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-13 | 4 | 4 | 2026-06-17 |
| 2026-06-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-29 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-06-25 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-06-24 | 4 | 4 | 2026-06-22 |
| 2026-06-24 | 3/A | 3/A | 2026-06-17 |
| 2026-06-24 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2026-06-22 |
| 2026-06-24 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2026-06-22 |
| 2026-06-23 | 8-K | 8-K items 5.03,9.01 | 2026-06-22 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
Forms on file (last 1,000): 4 17, 3 14, SCHEDULE 13G 4, 8-K 3, SCHEDULE 13D 2, SCHEDULE 13D/A 1, 10-Q 1, SCHEDULE 13G/A 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=KARD (0.002 USD), /gw/filings/filings?ticker=KARD&form=8-K, /gw/filings/facts?ticker=KARD&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange